Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hyaestic is a pharmaceutical-grade cosmeceutical company that focuses on advanced dermatological solutions for skin health and rejuvenation. The company specializes in high-potency topical formulations incorporating active ingredients such as hydroquinone, tretinoin, and vitamin C to treat complex skin conditions like hyperpigmentation, melasma, and acne. Hyaestic positions itself as a science-driven brand, bridging the gap between clinical dermatology and consumer skincare through rigorous ingredient selection and clinical testing. Their product portfolio is primarily distributed through professional channels, including dermatologists and medical spas, with a significant market presence in Southeast Asia and the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hyaestic.